• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study.

作者信息

Dhakal Binod, Rein Lisa, Szabo Aniko, Padmanabhan Anand

机构信息

Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.

Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI.

出版信息

Chest. 2020 Sep;158(3):1172-1175. doi: 10.1016/j.chest.2020.03.024. Epub 2020 Mar 26.

DOI:10.1016/j.chest.2020.03.024
PMID:32224075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7478227/
Abstract
摘要

相似文献

1
Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study.静脉注射免疫球蛋白G在肝素诱导的血小板减少症患者中的应用与血栓形成率增加无关：一项基于人群的研究。
Chest. 2020 Sep;158(3):1172-1175. doi: 10.1016/j.chest.2020.03.024. Epub 2020 Mar 26.
2
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia.静脉注射免疫球蛋白预防肝素诱导的血小板减少症。
N Engl J Med. 2018 May 10;378(19):1845-1848. doi: 10.1056/NEJMc1801799.
3
Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report.择期腹主动脉瘤修复术后持续存在的自身免疫性肝素诱导的血小板减少症：病例报告。
J Thromb Thrombolysis. 2020 Oct;50(3):674-677. doi: 10.1007/s11239-020-02062-2.
4
Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.静脉注射免疫球蛋白在肝素诱导的血小板减少症中的疗效。
Blood Coagul Fibrinolysis. 2020 Jul;31(5):287-292. doi: 10.1097/MBC.0000000000000918.
5
Heparin-induced thrombocytopenia--response to intravenous immunoglobulin in vivo and in vitro.
Am J Hematol. 1992 Apr;39(4):312-3. doi: 10.1002/ajh.2830390417.
6
Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.静脉注射免疫球蛋白（IVIG）治疗自身免疫性肝素诱导的血小板减少症：系统评价。
Ann Pharmacother. 2021 Feb;55(2):198-215. doi: 10.1177/1060028020943542. Epub 2020 Jul 21.
7
Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin.
Ann Intern Med. 1989 Dec 1;111(11):946-7. doi: 10.7326/0003-4819-111-11-946.
8
Delayed-onset heparin-induced thrombocytopenia and thrombosis.迟发性肝素诱导的血小板减少症和血栓形成。
Ann Intern Med. 2001 Oct 2;135(7):S-45.
9
IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.静脉注射免疫球蛋白治疗严重难治性肝素诱导的血小板减少症
Chest. 2017 Sep;152(3):478-485. doi: 10.1016/j.chest.2017.03.050. Epub 2017 Apr 17.
10
Emergency department awareness of heparin-induced thrombocytopenia: how frequently is risk assessment documented in patients with thrombosis?
Am J Med Qual. 2010 Sep-Oct;25(5):365-9. doi: 10.1177/1062860610366033. Epub 2010 Jun 3.

引用本文的文献

1
Perioperative Plasma Exchange and Intravenous Immunoglobulin Use for Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient.肝移植受者中难治性肝素诱导血小板减少症的围手术期血浆置换和静脉注射免疫球蛋白的应用。
Am J Case Rep. 2023 Dec 30;24:e941865. doi: 10.12659/AJCR.941865.
2
Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin-induced thrombocytopenia: A propensity matched analysis.出血与肝素诱导的血小板减少症中静脉注射免疫球蛋白和治疗性血浆置换的使用相关：一项倾向匹配分析。
EJHaem. 2021 May 7;2(3):466-470. doi: 10.1002/jha2.211. eCollection 2021 Aug.
3
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.肝素诱导的血小板减少症：发病机制、诊断及管理新概念综述
J Clin Med. 2021 Feb 10;10(4):683. doi: 10.3390/jcm10040683.
4
Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.肝素诱导的血小板减少症：关注血栓形成。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):141-152. doi: 10.1161/ATVBAHA.120.315445. Epub 2020 Dec 3.
5
Pathogenesis of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的发病机制。
Transl Res. 2020 Nov;225:131-140. doi: 10.1016/j.trsl.2020.04.014. Epub 2020 May 15.

本文引用的文献

1
Obesity in the Pediatric Population of the National (Nationwide) Inpatient Sample (NIS), USA.美国国家（全国性）住院患者样本（NIS）中的儿科肥胖人群
Cureus. 2022 Dec 29;14(12):e33111. doi: 10.7759/cureus.33111. eCollection 2022 Dec.
2
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.大剂量静脉注射免疫球蛋白治疗和预防肝素诱导的血小板减少症：综述。
Expert Rev Hematol. 2019 Aug;12(8):685-698. doi: 10.1080/17474086.2019.1636645. Epub 2019 Jul 5.
3
Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin.主动脉夹层修复术后自身免疫性肝素诱导的血小板减少症和静脉肢体坏疽：静脉注射免疫球蛋白的体内外作用。
Transfusion. 2019 Jun;59(6):1924-1933. doi: 10.1111/trf.15263. Epub 2019 Mar 23.
4
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.美国血液学会 2018 年静脉血栓栓塞症管理指南：肝素诱导的血小板减少症。
Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489.
5
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study.美国肝素诱导的血小板减少症的疾病负担、并发症发生率及医疗保健成本：一项基于人群的研究。
Lancet Haematol. 2018 May;5(5):e220-e231. doi: 10.1016/S2352-3026(18)30046-2.
6
Intravenous Immunoglobulin for Heparin-Induced Thrombocytopenia.静脉注射免疫球蛋白用于肝素诱导的血小板减少症。
Chest. 2017 Oct;152(4):906-907. doi: 10.1016/j.chest.2017.05.043.
7
Persistent Heparin-Induced Thrombocytopenia Treated With IVIg.静脉注射免疫球蛋白治疗持续性肝素诱导的血小板减少症
Chest. 2017 Sep;152(3):679-680. doi: 10.1016/j.chest.2017.05.044.
8
IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.静脉注射免疫球蛋白治疗严重难治性肝素诱导的血小板减少症
Chest. 2017 Sep;152(3):478-485. doi: 10.1016/j.chest.2017.03.050. Epub 2017 Apr 17.
9
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.静脉注射免疫球蛋白与血栓栓塞不良事件：随机对照试验的系统评价和荟萃分析。
Am J Hematol. 2016 Jun;91(6):594-605. doi: 10.1002/ajh.24358. Epub 2016 Apr 24.
10
Publication bias: what are the challenges and can they be overcome?发表偏倚：面临哪些挑战，这些挑战能否被克服？
J Psychiatry Neurosci. 2012 May;37(3):149-52. doi: 10.1503/jpn.120065.